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Abstract
Rodent-borne hantaviruses have received considerable attention in recent years due to the high
mortality rate in humans that their infections cause. Anthropogenic stressors are key factors in the
emergence of hantavirus-associated diseases. Urbanization, deforestation, noise pollution, artiﬁcial lighting
and electromagnetic ﬁelds are the most common forms of human impact on the environment. An
increased systemic concentration of the immunosuppressive class of steroid hormone glucocorticoid is
a frequent consequence of chronic anthropogenic stress. Elevated glucocorticoid levels play a crucial
role in modulating immune tolerance of rodents, thereby enabling establishment of the host-pathogen
interaction. Glucocorticoids support virus persistence in the reservoir host by activating an organ-speciﬁc
regulatory response mediated by T regulatory lymphocytes to reduce inﬂammatory and antiviral responses,
principally via production of cytokines interleukin-10 and transforming growth factor-β. In-depth analysis
of this mechanism would help to understand how rodents maintain a disease-free condition. This may
have implications for a cost-eﬀective intervention strategy against hantavirus and other zoonotic human
pathogens.
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Introduction
Hantavirus, a negative-sensed, enveloped, single
stranded RNA virus that belongs to the genus
Hantavirus and family Bunyaviridae, is a deadly
zoonotic virus harboured by rodents [1,2]. The RNA
genome of hantavirus consists of three elongated
and spherical segments, named large (L), medium (M)
and small (S), which code for RNA-dependent RNA
polymerase (RdRp), envelope glycoproteins (Gn and
Gc) and nucleocapsid (N), respectively [2]. Among
over 20 distinct hantavirus species at least 11 are
responsible for infection of humans [3]. While natural
reservoir rodents show no apparent sign of infection,
a person may develop potentially fatal clinical
disease manifestations [4]. Anthropogenic events
followed by anthropogenic stresses to rodents
are recognized as a major driving force for the
emergence of hantavirus in rodents [5]. These
anthropogenic stresses have deleterious eﬀects
on a rodent’s endocrine, immune, nervous and
physiological systems and hence alter the overall
functioning of its tissues and organs. Rodents
exposed to chronic anthropogenic stress express
elevated levels of glucocorticoid (GC) hormone.
This is accountable for reducing the resistance of
rodents to viruses and increasing their tolerance
to viral load of the reservoir host [6]. To facilitate
virus persistence in stressed rodents GC activates
an organ-speciﬁc regulatory mechanism, governed
primarily by T regulatory (Treg) lymphocytes and
interleukin (IL)-10, to reduce the inﬂammatory
response during infection. This review focuses
on why an understanding of factors behind viral
emergence is important, discusses the part played
by GC hormone in virus persistence and host
immune response to infection, and considers current
therapeutic measures to both prevent outbreaks and
treat cases of hantavirus.
Epidemiology and pathogenesis
Humans are the dead-end host for hantavirus and
become infected when coming into close contact
with egestion, excretions or secretions, or soiled
nesting material, of infected rodents. The most
frequent route of transmission is airborne, via
inhalation of aerosols containing virus particles [7,8].
The distribution of hantavirus species is determined
by the geographical location of their natural reservoir
rodents [9]. Individuals living in housing with poor
ventilation or containing urine, saliva or fresh
droppings from infected rodents, or on agricultural
land with an abundant rodent population, are most at
risk of infection [9,10]. Long-term forest habitation,
such as by military personnel, also increases exposure
to the virus [11]. Disturbed natural environments and
destruction of habitat promote loss of biodiversity
and drive the migration of infected rodents into
areas heavily populated by humans, which results in
raised rates of pathogen transmission. Russia and
China report the most cases of hantavirus infection
in Europe and Asia, respectively [12].
Hantavirus-associated clinical syndromes in
humans can be classiﬁed in either of two categories:
2haemorrhagic fever with renal syndrome (HFRS);
and hantavirus pulmonary syndrome (HPS). Although
HFRS and HPS share some common clinical
symptoms, which include overexpression of CD8+
T lymphocytes, increased vascular permeability and
elevated leucocytes in peripheral blood, some
features, notably mortality rates, diﬀer [13].
As the name indicates, renal involvement with
haemorrhagic fever is associated most often with
HFRS. The course of clinical development of HFRS is
divided into ﬁve distinct stages: febrile; hypotensive;
oliguric; diuretic; and convalescent. The mortality
rate due to HFRS is 5-15% [14]. HPS is characterized
by inﬂuenza-like symptoms including headache, high
fever and myalgia. Hypotension and pulmonary
oedema may develop which often deteriorates
rapidly into acute respiratory failure, resulting in a
high mortality rate of around 50% [14,15].
Role of anthropogenic stressors as a key factor
for emergence
A key factor in the emergence of hantavirus
as well as of many other emerging infectious
diseases is the eﬀect of anthropogenic stresses
to wildlife, which is a direct consequence of man-
made disturbances to the natural environment[16].
Commonly recognized anthropogenic stressors
include urbanization, deforestation, noise pollution,
light pollution and electromagnetic radiation.
Rodents are considered to serve as a suitable
reservoir for more than 60 human-infecting viruses,
which should be a serious concern for public health
[17].
The most prevalent adverse eﬀects of
urbanization are habitat fragmentation, loss of
biodiversity, food scarcity, high food competition and
deforestation, all of which act as chronic stressors for
rodents. In response to such stimuli, rodents express
elevated levels of GC which lower their immunity to
viruses and alter their endocrine and physiological
balance [18,19]. Furthermore, loss of biodiversity
increases risks of pathogen transmission [20].
Rodents that are exposed to chronic noise show
signiﬁcant physiological alterations which include
increased corticosterone, modulated immunity,
and reductions in body weight, gastric secretion
and reproductive activity, none of which is
observed in rodents kept under conditions of
low noise or unbroken silence [21,22]. Signiﬁcant
reductions in T lymphocyte concentration, humoral
immune response and phagocytic activity are also
experienced by noise-exposed rodents [23].
Prolonged artiﬁcial lighting at night reduces
body temperature, suppresses circadian activity and
initiates sleep deprivation in rodents. This further
activates the hypothalamic-pituitary-adrenal axis to
produce elevated levels of GC [24-26]. Suppression
of cell-mediated and humoral immune responses are
also observed in artiﬁcial light-exposed rodents [27].
Similarly, extended exposure to electromagnetic
ﬁelds acts as a chronic stressor of rodents, which
causes increased GC production and, subsequently,
suppression of cellular immunity [28,29].
Hantavirus outbreaks occur most often in
environments that are extensively disturbed due
to anthropogenic changes of the type described
above. Hence, the impact of anthropogenic
stressors on hantavirus emergence should be given
consideration because the interaction between
endocrine, immune and nervous systems is a
signiﬁcant inﬂuence on the outcome of the host-
parasite interaction [5,30]. Each class of chronic
stressor is capable of reducing a rodent’s resistance
to infection [31]. A stress response is characterized
by increased GC expression, the eﬀects of which
in rodents are classiﬁed into ﬁve categories:
increased blood glucose; reduced growth; decreased
reproductive performance; altered behaviour; and
suppressed immunity [32,33]. Chronic stress-induced
GC contributes to a rodent’s susceptibility to
infection by reducing its antiviral resistance and
elevating its tolerance to viruses. This viral
persistence mechanism is directed by a complex
cytokine cascade orchestrated by Treg lymphocytes
[6,34] (Figure 1).
Persistence and immune response – role of
glucocorticoid hormone
Understanding the mechanisms of hantavirus
persistence and of host immunity to chronic infection
is fundamental to development of future antiviral
therapies. The means by which rodents support
hantavirus without showing any symptoms of disease
is just starting to be revealed. Hantavirus-associated
clinical manifestations in humans are considered
to be due to excessive pro-inﬂammatory and
CD8+ T lymphocyte responses while rodents exhibit
lower pro-inﬂammatory and antiviral responses and
elevated regulatory responses [35,36].
During infection, monocytes and macrophages
are the ﬁrst immune cells to become infected.
The virus expresses elevated levels of the enzyme
matrix metallopeptidase 9 which disrupts the
cell membrane, thereby facilitating dissemination
into tissues [37]. Reduced expression of antiviral
interferon (IFN)-β, IFN-γ and other pro-inﬂammatory
cytokines is observed in chronically infected rodents
[36]. Depletion of CD8+ T lymphocytes results in
increased viral load and mortality, which is a clear
indication of the crucial role of these cells in
suppressing hantavirus replication and host infection
[38,39]. Treg lymphocytes act to suppress pro-
inﬂammatory and CD8+ T cell activity to maintain host
homeostasis and thereby enable viral persistence
(Figure 1). Inactivation of Treg lymphocytes reduces
expression of viral RNA in rat lungs, which is indicative
of Treg involvement in hantavirus persistence [40]. Treg
lymphocytes further suppress expression of tumour
necrosis factor (TNF)-α and inﬂammatory responses
and promote expression of transforming growth
factor (TGF)-β, IL-10 and the transcription factor
Foxp3 [41]. T helper (Th) 1 CD4+ lymphocytes express
IFN-γ, IL-2 and TNF-α which also activates CD8+ T
lymphocytes, NK cells and macrophages [42], while
Th2 lymphocytes express IL-4, IL-5, IL-10 and IL-13 and
trigger antibody-mediated immunity [43].
3Figure 1 General overview of glucocorticoid-mediated hantavirus emergence and persistence in rodents.
Treg lymphocytes initiate Th1-Th2 pathway
polarization and also suppress the activity of
antigen-presenting cells, such as dendritic cells
(DC), macrophages and B lymphocytes [44-46].
Furthermore, Treg lymphocytes may be activated by
immature or tolerogenic DC mediated by TGF-β to
exert regulatory activity [45,47].
The anti-inﬂammatory role of GC is well
established. While chronic stress-induced GC is
responsible for immune suppression of rodents,
it likely activates an organ-speciﬁc regulation
that supports hantavirus persistence. GC blocks
inﬂammatory pathways and induces apoptosis
mediated by Treg lymphocytes [48-50]. GC not only
suppresses diﬀerentiation of DC but also induces
production of tolerogenic DC which express elevated
IL-10 and TGF-β. Tolerogenic DC are responsible
for generation and activation of Treg lymphocytes to
exert a regulatory control over CD8+ lymphocyte-
mediated antiviral responses [51,52]. GC initiates a
polarization of CD4+ lymphocyte subsets from Th1
to Th2 and increased production of Th2 cytokines
which further trigger alternatively activated M2
macrophages [52] (Figure 1). M2 macrophages are
characterized by increased production of IL-10 and
TGF-β, stimulated mainly by elevated levels of GC,
which also suppresses activity of naturally activated
M1 macrophages [52,53]. Depletion of GC leads
to high mortality rates due to an excessive pro-
inﬂammatory cytokine response despite eﬃcient
virus clearance. This is indicative of the critical role of
GC in viral persistence and establishing an equitable
balance in the host-pathogen interaction [54,55].
Current approaches to therapy and prevention
There is currently no drug that is approved
by the US Food and Drug Administration for
treatment of hantavirus infection. Ribavirin (1-β-
D-ribofuranosyl-1,2,4-triazole-3-carboxamide) shows
some anti-hantaviral activity both in vitro and
in vivo but not suﬃcient to consider it further
for commercial development [56,57]. Considerable
eﬀorts have been invested in designing an
eﬃcacious vaccine against hantavirus but progress
is slow. A conventional vaccination approach is
followed in Asia, which includes rodent brain-
and cell culture-derived inactivated vaccines [58]
and in Korea mouse brain-derived Hantavax® was
marketed commercially [59]. However, none of these
is approved in the US for therapeutic use since
they do not provide protective immunity against
multiple pathogenic species [60,61]. Therefore,
current vaccine strategies are focused mainly on
developing a DNA vaccine that would protect against
a range of pathogenic species. Initial ﬁndings indicate
that a quadrivalent vaccine could be a promising
option for future vaccine research [62].
As successful prophylaxis or treatment for
hantavirus-associated clinical syndromes is not an
immediate prospect, low technology prevention
strategies remain the best tool to minimize the
impact of infection. Avoidance of contact with
rodents and their secretions is the simplest way to
prevent infection. However, farmers and workers in
other occupations at risk of exposure to abundant
rodent populations are advised to wear a face mask
to help prevent acquiring disease via inhalation
of infected aerosols. Proper ventilation with fresh
air is another way to keep infrequently used
accommodation free from risk of transmission [63].
Conclusions
The recent repeated emergence and reemergence
of infectious diseases highlight the urgent need for
eﬀective public health surveillance and management
systems. Anthropogenic stressors to wildlife are
4key factors behind viral disease outbreaks, so
future research should consider a multi-disciplinary
strategy which involves all aspects of the virus
life cycle. This includes understanding the host-
pathogen relationship in the reservoir, in particular,
how wild animals maintain a disease-free condition
while supporting virus persistence. In the case of
hantavirus, this interaction is governed by GC, so
further study should focus on how GC and Treg
lymphocytes react under conditions of infection.
A systematic comparison of immune responses
following infection of human and rodent, and also
with respect to immunological proﬁles of wild
rodents, may help to reveal the roles of GC and
Treg lymphocytes under diﬀerent conditions and their
interactions in antiviral responses in an organ-speciﬁc
manner. This may facilitate the development of an
eﬀective antiviral therapeutic agent and alleviate
issues associated with current therapies.
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